209 related articles for article (PubMed ID: 12898190)
1. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody.
Gholam D; Vantelon JM; Al-Jijakli A; Bourhis JH
Ann Hematol; 2003 Dec; 82(12):766-8. PubMed ID: 12898190
[TBL] [Abstract][Full Text] [Related]
2. Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab.
Ide M; Kawachi Y; Izumi Y; Kasagi K; Ogino T
Eur J Haematol; 2006 Feb; 76(2):119-23. PubMed ID: 16405432
[TBL] [Abstract][Full Text] [Related]
3. Multicentric Castleman's disease treated with combination chemotherapy and rituximab in four HIV-positive men: a case series.
Bestawros A; Michel R; Séguin C; Routy JP
Am J Hematol; 2008 Jun; 83(6):508-11. PubMed ID: 18027834
[TBL] [Abstract][Full Text] [Related]
4. Multicentric Castleman's disease in a patient with HIV.
Fowler A; Collins L; de Ruiter A; Whittaker S; Kulasegaram R; Bradbeer C
Int J STD AIDS; 2006 Jan; 17(1):63-4. PubMed ID: 16409683
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.
Gérard L; Bérezné A; Galicier L; Meignin V; Obadia M; De Castro N; Jacomet C; Verdon R; Madelaine-Chambrin I; Boulanger E; Chevret S; Agbalika F; Oksenhendler E
J Clin Oncol; 2007 Aug; 25(22):3350-6. PubMed ID: 17664482
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report.
Flejsierowicz M; Ahmed MS; Kotov P; Cheng YC
WMJ; 2008 Jul; 107(4):191-4. PubMed ID: 18702436
[TBL] [Abstract][Full Text] [Related]
7. Rituximab failure in fulminant multicentric HIV/human herpesvirus 8-associated Castleman's disease with multiorgan failure: report of two cases.
Buchler T; Dubash S; Lee V; Chilton D; Cartledge J; Isaacson P; Tedder RS; Lee SM
AIDS; 2008 Aug; 22(13):1685-7. PubMed ID: 18670234
[No Abstract] [Full Text] [Related]
8. HIV-associated multicentric Castleman's disease.
Stebbing J; Pantanowitz L; Dayyani F; Sullivan RJ; Bower M; Dezube BJ
Am J Hematol; 2008 Jun; 83(6):498-503. PubMed ID: 18260115
[TBL] [Abstract][Full Text] [Related]
9. Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide.
Lee FC; Merchant SH
Am J Hematol; 2003 May; 73(1):48-53. PubMed ID: 12701121
[TBL] [Abstract][Full Text] [Related]
10. Human herpesvirus 8 DNA in HIV-negative Japanese patients with multicentric Castleman's disease and related diseases.
Tohda S; Murakami N; Nara N
Int J Mol Med; 2001 Nov; 8(5):549-51. PubMed ID: 11605026
[TBL] [Abstract][Full Text] [Related]
11. Multicentric Castleman's disease & HIV infection.
Cotter A; Lambert J; O'Gorman P
Ir Med J; 2009 Oct; 102(9):294-5. PubMed ID: 19902650
[TBL] [Abstract][Full Text] [Related]
12. Plasmablastic microlymphoma occurring in human herpesvirus 8 (HHV-8)-positive multicentric Castleman's disease and featuring a follicular growth pattern.
Dargent JL; Lespagnard L; Sirtaine N; Cantinieaux B; Li R; Hermans P
APMIS; 2007 Jul; 115(7):869-74. PubMed ID: 17614857
[TBL] [Abstract][Full Text] [Related]
13. Multicentric Castleman's disease in HIV infection.
Collins LS; Fowler A; Tong CY; de Ruiter A
Int J STD AIDS; 2006 Jan; 17(1):19-24; quiz 25. PubMed ID: 16409673
[TBL] [Abstract][Full Text] [Related]
14. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease.
Neuville S; Agbalika F; Rabian C; Brière J; Molina JM
Am J Hematol; 2005 Aug; 79(4):337-9. PubMed ID: 16044438
[TBL] [Abstract][Full Text] [Related]
15. The first reported case and management of multicentric Castleman's disease associated with Kaposi's sarcoma in an HIV-2-infected patient.
Bouvresse S; Marcelin AG; Franck N; Regnier S; Damond F; Tulliez M; Dupin N
AIDS; 2007 Jul; 21(11):1492-4. PubMed ID: 17589201
[No Abstract] [Full Text] [Related]
16. Angiofollicular lymph node hyperplasia resembling a spinal nerve sheath tumor: a rare case of Castleman's disease.
Stevens EA; Strowd RE; Mott RT; Oaks TE; Wilson JA
Spine J; 2009 Sep; 9(9):e18-22. PubMed ID: 19482516
[TBL] [Abstract][Full Text] [Related]
17. Secondary amyloidosis in Castleman's disease: review of the literature and report of a case.
Altiparmak MR; Pamuk GE; Pamuk ON; Doğusoy G
Ann Hematol; 2002 Jun; 81(6):336-9. PubMed ID: 12107565
[TBL] [Abstract][Full Text] [Related]
18. IL-1RA agonist (anakinra) in the treatment of multifocal castleman disease: case report.
Galeotti C; Tran TA; Franchi-Abella S; Fabre M; Pariente D; Koné-Paut I
J Pediatr Hematol Oncol; 2008 Dec; 30(12):920-4. PubMed ID: 19131781
[TBL] [Abstract][Full Text] [Related]
19. Multicentric Castleman's disease complicated by tumor lysis syndrome.
Lee KD; Lee KW; Choi IS; Yoon SS; Park S; Kim BK; Kim NK
Ann Hematol; 2004 Nov; 83(11):722-5. PubMed ID: 15316754
[TBL] [Abstract][Full Text] [Related]
20. A case of multicentric Castleman's disease in HIV infection with the rare complication of acquired angioedema.
Fernando I; Scott G
Int J STD AIDS; 2014 Jun; 25(7):523-5. PubMed ID: 24352125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]